U.S. FDA approves Akebia’s anemia drug

By Thomson Reuters Mar 27, 2024 | 7:44 PM

(Reuters) – The U.S. Food and Drug Administration approved Akebia Therapeutics’ drug to treat anemia caused by chronic kidney disease in dialysis patients, the drugmaker said on Wednesday.

(Reporting by Pratik Jain, Vaibhav Sadhamta and Mrinmay Dey in Bengaluru; Editing by Subhranshu Sahu)